ClinicalTrials.gov
public full text
Public Domain
A Relative Bioavailability Study of Sertraline HCl 100 mg Tablets Under Non-fasting Conditions
To compare the rate of absorption and oral bioavailability of a test formulation of Sertraline 100 mg tablets manufactured by Purepac Pharmaceutical Company to an equivalent oral dose of the commercially available reference product, Zoloft® manufactured by Pfizer Inc. Following an overnight fast of at least 10 hours, subjects will consume a standard high-calorie, high-fat breakfast meal. This standard breakfast will begin 30 minutes prior to each dose.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Relative Bioavailability Study of Sertraline HCl 100 mg Tablets Under Fasting Conditions#898872
- Relative Bioavailability Study of Zoloft Oral Solution to Zoloft Tablets#1045918
- Pharmacokinetics and Pharmacodynamics of Oral Sertraline Before and After Bariatric Surgery#839641
- Bioequivalency Study of Sertraline Under Fed Conditions#1214357
- Bioequivalence Trial of Alprazolam 2 mg Tablets#893842
Record · ID 1213275
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive